Group One Trading’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
OAG
PA
BBA
VCM
DM
DCM
CAM
Group One Trading's PRAX Position: Q1 2026 in Review
Group One Trading reduced its Praxis Precision Medicines (PRAX) stake by 98% in Q1 2026, selling an estimated $1.67M and leaving 129 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5395.
Group One Trading first reported a position in PRAX in Q1 2022 and has held it in 13 quarters since. The position peaked at $3.5M in Q3 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.
- Group One Trading held 129 shares of Praxis Precision Medicines worth $41.6K as of Q1 2026.
- Group One Trading sold 5,410 Praxis Precision Medicines shares in Q1 2026, an estimated $1.67M.
- Praxis Precision Medicines made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5395 holding.
- Group One Trading first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 13 quarters since.
- Group One Trading's Praxis Precision Medicines position peaked at $3.5M in Q3 2024.
- 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.